Intractable Pneumothorax Treatment Markett
Intractable Pneumothorax Treatment Market -
Industry Trends and Forecast to 2026 with key players like Medtronic, Angiotech, BetaGlue,
Teleflex Incorporated, Vygon SA, Utah Medical Products, Inc, Smiths Group plc,
ATMOS MedizinTechnik GmbH & Co. KG, Sinapi Biomedical
Intractable
Pneumothorax Treatment Market By Types (Traumatic Pneumothorax and
Nontraumatic Pneumothorax), Drugs Class (Antibiotics, Benzodiazepines, Opiate
Anesthetics and Others), Diagnosis (Chest Radiography, CT Scan, Thoracic
Ultrasound and Others), Treatment (Medications, Supportive Care and Surgery),
Route of Administration (Oral, Inhalation and Parenteral), Distribution Channel
(Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), End-Users (Hospitals,
Homecare, Specialty Clinics and Others), Geography (North America, Europe,
Asia-Pacific, South America, Middle East and Africa) - Industry Trends and
Forecast to 2026
Market Analysis: Global
Intractable Pneumothorax Treatment Market
Global intractable
pneumothorax treatment market is growing at a steady CAGR in the forecast
period of 2021-2026. The report contains data of the base year 2018 and
historic year 2017. Increasing prevalence of respiratory diseases such as COPD
and asthma, increasing aging population across the world, along with the rising
healthcare expenditures are certain factors which can augment the growth of
this market.
Download full sample report of Intractable
Pneumothorax Treatment Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-intractable-pneumothorax-treatment-market
Market Definition:
Global Intractable Pneumothorax Treatment Market
Intractable pneumothorax
is a condition of collapsed lung. This condition occurs when air leaks out
in-between the spaces of lung and chest wall. This air puts pressure on the
lungs from outside and makes it collapse, this can results in a complete lung collapse
or a collapse of only a portion of the lung. Pneumothorax can be caused by
chest injuries which penetrates the lungs, certain medical procedures, or from
any lung disease. Symptoms include sudden chest pain and shortness of breath.
Market Drivers
Increasing prevalence of respiratory diseases such as COPD and
asthma is driving the market growth
Availability of effective treatment for the pneumothorax across
different regions is boosting the market growth
Increasing awareness about the various respiratory diseases is
expected to drive the market growth
Rising healthcare expenditures can also act as a driver for the
growth of this market
Market Restraints
Delayed diagnosis and low rate of diagnosis of pneumothorax is
hampering the market growth
Lack of awareness about the pneumothorax in underdeveloped
countries as well as developing countries is also hindering the growth of this
market
Limited availability of medicinal treatment options can act as a
major restricting factor in this market growth
Segmentation: Global Intractable
Pneumothorax Treatment Market
By Types
·
Traumatic
Pneumothorax
·
Nontraumatic
Pneumothorax
By Drugs Class
·
Antibiotics
·
Benzodiazepines
·
Opiate
Anesthetics
·
Others
By Diagnosis
·
Chest
Radiography
·
CT
Scan
·
Thoracic
Ultrasound
·
Others
By Treatment
·
Medications
·
Supportive
Care
·
Surgery
By Route of Administration
·
Oral
·
Inhalation
·
Parenteral
By Distribution Channel
·
Hospital
Pharmacy
·
Retail
Pharmacy
·
Online
Pharmacy
By End-Users
·
Hospitals
·
Homecare
·
Specialty
Clinics
By Geography
·
North
America
·
U.S.
·
Canada
·
Mexico
·
Europe
·
Germany
·
Italy
·
U.K.
·
France
·
Spain
·
Netherlands
·
Belgium
·
Switzerland
·
Turkey
·
Russia
·
Rest
of Europe
·
Asia-Pacific
·
Japan
·
China
·
India
·
South
Korea
·
Australia
·
Singapore
·
Malaysia
·
Thailand
·
Indonesia
·
Philippines
·
Rest
of Asia Pacific
·
South
America
·
Brazil
·
Rest
of South America
·
Middle
East & Africa
·
South
Africa
·
Rest
of Middle East & Africa
Key Developments in the Market
In August 2019, Nobelpharma Co., Ltd is developing Unitalc for
the treatment of patients with intractable pneumothorax, currently ongoing in
phase ll clinical trial. If approved this drug will provide the potential
treatment for the patients with pneumothorax
In May 2019, Zebra Medical Vision, Inc received the 510(k) U.S
FDA approval for HealthPNX - an AI alert for pneumothorax, based on chest
X-rays. Approval of this device will help in the early diagnosis of
pneumothorax further assisting in improving the patient care
Competitive Analysis:
Global
intractable pneumothorax treatment market is highly fragmented and the
major players have used various strategies such as new product launches,
expansions, agreements, joint ventures, partnerships, acquisitions, and others
to increase their footprints in this market. The report includes market shares
of intractable pneumothorax treatment drug market for Global, Europe, North
America, Asia-Pacific, South America and Middle East & Africa.
Key Market Players:
The key market players
in the global intractable pneumothorax treatment market are Abbott, ,
Medtronic, Angiotech, BetaGlue, Teleflex Incorporated, Vygon SA, Utah Medical
Products, Inc, Smiths Group plc, ATMOS MedizinTechnik GmbH & Co. KG, Sinapi
Biomedical, , Nobelpharma Co., Ltd, Zebra Medical Vision, Inc among others.
Get full details of TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-intractable-pneumothorax-treatment-market
Reasons
for Buying this Report
This report provides pin-point analysis for changing
competitive dynamics
It provides a forward looking perspective on different
factors driving or restraining market growth
It provides a six-year forecast assessed on the basis
of how the market is predicted to grow
It helps in understanding the key product segments and
their future
It provides pin point analysis of changing competition
dynamics and keeps you ahead of competitors
It helps in making informed business decisions by
having complete insights of market and by making in-depth analysis of market
segments
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-intractable-pneumothorax-treatment-market
About
Us:
Data
Bridge Market Research set
forth itself as an unconventional and neoteric Market research and consulting
firm with unparalleled level of resilience and integrated approaches. We are
determined to unearth the best market opportunities and foster efficient
information for your business to thrive in the market
Contact:
Tel:
+1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Browse
Related Reports @
PDLC (Polymer Dispersed Liquid Crystal) for
Smart Window Market